MedTrace Logo

Gut Microbiota and Antibiotics - Prevention of Side Effects by New Prebiotics

NCT03523936 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2018-05-14

No results posted yet for this study

Summary

Antibiotics disturb the balance of gut microbiota causing dysbiosis. The purpose of this double-blind placebo controlled intervention study is to investigate whether a new prebiotic product could prevent the side effects of antibiotics.

Conditions

  • Changes in the Gut Microbiota During an Antibiotic Treatment

Interventions

DIETARY_SUPPLEMENT

Prebiotic product

Prebiotic product used during the course of antibiotic treatment

DIETARY_SUPPLEMENT

Placebo

Placebo

Sponsors & Collaborators

  • VTT Technical Research Centre of Finland

    collaborator OTHER

  • Turku University Hospital

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-01
Primary Completion
2019-12-31
Completion
2019-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03523936 on ClinicalTrials.gov